After the company reported fourth-quarter results that failed to excite investors, shares ofImpax Laboratories (NASDAQ: IPXL)are losing 29% of their value at 12:00 p.m. EST Wednesday. Since 2015, ...
Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue. Here are four things to know about the deal. 1. Under the ...
Oct 9 (Reuters) - Impax Laboratories Inc said it gained access to an emergency anti-allergen injection, epinephrine, by acquiring two privately held Pennsylvania drugmakers for $700 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results